Orthopedic Biologics Procurement for Beaumont, Texas Practices

How orthopedic practices in this region structure vendor review

Orthopedic surgery centers along the Gulf Coast region of Texas commonly assign vendor qualification to a practice administrator who checks three things before approving a new biologics supplier: whether each lot ships with a certificate of analysis, whether donor eligibility and sterility testing records are available on request, and whether the supplier's account terms fit the center's existing purchasing and billing workflow.

Surgery centers that already carry other allograft products in inventory often ask how our products fit alongside those lines; Precision Biologics distributes a defined set of seven Wharton's jelly and exosome products and can walk new accounts through that catalog during onboarding.

NPI-verified account setup

A valid NPI number is required to open an account, whether the order is placed by a solo orthopedic surgeon or under a surgery center's group NPI with a named licensed provider.

Shipping and receiving for Southwest region practices

Cryopreserved products ship overnight on dry ice in validated containers regardless of destination, and each shipment is tracked by lot number from dispatch. Practices in this region should plan receiving around standard overnight carrier schedules and confirm dry ice integrity and vial condition on arrival before logging the lot number into the patient traceability record. Bio DPM, the lyophilized Wharton's jelly format, ships without dry ice and stores per the product insert, which some centers use to simplify inventory for lower-volume products.

Verification and ongoing support

We recommend confirming each provider's license status with the Texas Medical Board and directing any questions about intended use to independent counsel. These products are not FDA approved or licensed for any disease or condition. Verified accounts have access to peer-to-peer physician calls focused on documentation, and we provide certificates of analysis and lot release records on request.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.